文献速递外周动脉疾病

糖尿病不恶化膝下搭桥或腔内治疗的重度肢体缺血结局

Diabetes does not worsen outcomes following infrageniculate bypass or endovascular intervention for patients with critical limb ischemia.
PubMed 文献 · J Vasc Surg · 2016-01-01

基于2008-2014年VQI数据,纳入2566例因静息痛或组织缺损行膝下或跨膝搭桥(LEB)或外周血管介入(PVI)的重度肢体缺血患者,比较糖尿病与非糖尿病患者的1年结局。结果显示两组在LEB和PVI后的1年一期通畅率、大截肢率和死亡率均无显著差异,多因素校正后糖尿病组通畅率有非显著劣势趋势,但截肢和死亡无差异。

要点

  • 膝下或跨膝血运重建后,糖尿病与非糖尿病患者的1年一期通畅率、大截肢率和死亡率无显著差异。
  • 多因素校正后,糖尿病组LEB后通畅率有非显著更差趋势(HR 1.55,95%CI 1.00-2.42,P=.05)。
  • 无论是否合并糖尿病,重度肢体缺血患者均应积极尝试保肢治疗。

核心结论

  • 膝下或跨膝动脉闭塞导致的重度肢体缺血,开放搭桥或腔内治疗在糖尿病与非糖尿病患者中均可成功实施。
  • 糖尿病状态不加重膝下或跨膝血运重建后的1年通畅率、大截肢率或死亡率。

研究设计与样本

  • 回顾性分析2008-2014年Vascular Quality Initiative(VQI)数据。
  • 纳入因静息痛或组织缺损行膝下或跨膝LEB或PVI的患者,共2566例。
  • LEB组500例(糖尿病355例 vs 非糖尿病145例),PVI组2066例(糖尿病1463例 vs 非糖尿病603例)。

主要发现

  • 糖尿病患者更常见黑人(18% vs 14%)、更多合并症、更多因组织缺损行血运重建(85% vs 58%),均P<.001。
  • LEB组糖尿病 vs 非糖尿病:1年一期通畅率74% vs 71%(P=.52),大截肢率16% vs 12%(P=.39),死亡率10% vs 6%(P=.16)。
  • PVI组糖尿病 vs 非糖尿病:1年一期通畅率81% vs 79%(P=.36),大截肢率14% vs 11%(P=.09),死亡率6% vs 7%(P=.30)。
  • 多因素校正后,LEB后通畅率糖尿病组HR 1.55(95%CI 1.00-2.42,P=.05),PVI后HR 1.23(95%CI 0.97-1.56,P=.09)。
  • 风险校正后,LEB或PVI的1年大截肢或死亡率在糖尿病与非糖尿病间均无显著差异(P≥.16)。

关键数值与推荐

  • LEB组1年一期通畅率74% vs 71%(P=.52),大截肢率16% vs 12%(P=.39),死亡率10% vs 6%(P=.16)。
  • PVI组1年一期通畅率81% vs 79%(P=.36),大截肢率14% vs 11%(P=.09),死亡率6% vs 7%(P=.30)。
  • 多因素分析LEB通畅率HR 1.55(95%CI 1.00-2.42,P=.05),PVI通畅率HR 1.23(95%CI 0.97-1.56,P=.09)。

临床怎么用

  • 对合并糖尿病的重度肢体缺血患者,膝下或跨膝开放搭桥或腔内治疗均可作为有效血运重建方式。
  • 糖尿病状态不应成为放弃保肢尝试的理由,应积极评估血运重建。

局限性

  • 原文未报告局限性描述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Both open surgery and endovascular peripheral interventions have been shown to effectively improve outcomes in patients with peripheral arterial disease, but minimal data exist comparing outcomes performed at and below the knee among patients with diabetes (DM) specifically. The purpose of this study is to compare outcomes following open bypass (lower extremity bypass [LEB]) and peripheral vascular intervention (PVI) at and below the knee in patients with DM vs patients without DM (non-DM) with critical limb ischemia. METHODS: Data from the 2008-2014 Vascular Quality Initiative (VQI) were analyzed. All patients undergoing LEB or PVI at or below the knee for rest pain or tissue loss were included. One-year primary patency, major amputation, and mortality were compared for patients with DM vs patients without DM stratified by treatment approach. RESULTS: Overall, 2566 patients were included, including 500 patients (19%) undergoing LEB (DM = 355 vs non-DM = 145) and 2066 patients (81%) undergoing PVI (DM = 1463 vs non-DM = 603). Patients with DM were more frequently black (18% vs 14%), had more comorbidities, and more frequently underwent revascularization for tissue loss (85% vs 58%) compared with patients without DM (all, P < .001). Within the LEB group, there were no significant differences in 1-year primary patency (74% vs 71%; P =.52), major amputation (16% vs 12%; P = .39), or mortality (10% vs 6%; P =.16) between DM vs non-DM patients. There were also no significant differences in 1-year primary patency (81% vs 79%; P = .36), major amputation (14% vs 11%; P =.09) or mortality (6% vs 7%; P =.30) among patients with DM vs patients without DM undergoing PVI. Multivariable analysis adjusting for baseline differences between groups demonstrated a nonsignificant trend toward better primary patency in the DM group following both LEB (hazard ratio, 1.55; 95% confidence interval, 1.00-2.42; P = .05) and PVI (hazard ratio, 1.23; 95% confidence interval, 0.97-1.56; P = .09). There were no significant differences in 1-year major amputation or mortality comparing patients with DM vs patients without DM for either LEB or PVI after risk adjustment (all, P ≥ .16). CONCLUSIONS: Critical limb ischemia resulting from arterial occlusive disease at or below the knee can be treated successfully with either open surgical bypass or endovascular interventions in both DM and non-DM patients. Aggressive attempts at limb salvage among patients with critical limb ischemia should be pursued regardless of DM status.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Hicks CW, Najafian A, Farber A, et al. Diabetes does not worsen outcomes following infrageniculate bypass or endovascular intervention for patients with critical limb ischemia. J Vasc Surg. 2016. PMID: 27871493. doi:10.1016/j.jvs.2016.07.107

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。